MarketBeat on MSN

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite?

CompanyOverview|NASDAQ:RXRX] Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to ...
Seeking Alpha

Recursion Pharmaceuticals: High-Risk Play Getting Riskier By The Quarter

Recursion Pharmaceuticals' stock has plummeted 57% since February, with significant failures in its lead drug REC-994 and other clinical candidates, raising concerns about its AI-driven drug discovery ...